Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board.

Journal: European urology focus
Published Date:

Abstract

Robot-assisted radical cystectomy (RARC) continues to expand, and several surgeons start training for this complex procedure. This calls for the development of a structured training program, with the aim to improve patient safety during RARC learning curve. A modified Delphi consensus process was started to develop the curriculum structure. An online survey based on the available evidence was delivered to a panel of 28 experts in the field of RARC, selected according to surgical and research experience, and expertise in running training courses. Consensus was defined as ≥80% agreement between the responders. Overall, 96.4% experts completed the survey. The structure of the RARC curriculum was defined as follows: (1) theoretical training; (2) preclinical simulation-based training: 5-d simulation-based activity, using models with increasing complexity (ie, virtual reality, and dry- and wet-laboratory exercises), and nontechnical skills training session; (3) clinical training: modular console activity of at least 6 mo at the host center (a RARC case was divided into 11 steps and steps of similar complexity were grouped into five modules); and (4) final evaluation: blind review of a video-recorded RARC case. This structured training pathway will guide a starting surgeon from the first steps of RARC toward independent completion of a full procedure. Clinical implementation is urgently needed. PATIENT SUMMARY: Robot-assisted radical cystectomy (RARC) is a complex procedure. The first structured training program for RARC was developed with the goal of aiding surgeons to overcome the learning curve of this procedure, improving patients' safety at the same time.

Authors

  • Paolo Dell'Oglio
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
  • Filippo Turri
    Department of Urology, University of Modena and Reggio Emilia, Modena, Italy.
  • Alessandro Larcher
    Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Frederiek D'Hondt
    General Surgery and Urology. OLV Hospital. Belgium.
  • Rafael Sanchez-Salas
    Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Bernard Bochner
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Joan Palou
    Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Robin Weston
    Department of Urology, Royal Liverpool University Hospital, Liverpool, UK.
  • Abolfazl Hosseini
  • Abdullah E Canda
    Department of Urology, School of Medicine, Koc University, Istanbul, Turkey.
  • Jørgen Bjerggaard
    Department of Clinical Medicine-Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
  • Giovanni Cacciamani
    Department of Urology, Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Kasper Ørding Olsen
    Department of Clinical Medicine-Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
  • Inderbir Gill
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Thierry Piechaud
    Department of Urology, Clinique Saint Augustin, Bordeaux, France.
  • Walter Artibani
    Urology Clinic, A.O.U.I. Verona, Verona, Italy.
  • Pim J van Leeuwen
    Department of Urology, Antoni Van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Arnulf Stenzl
    Department of Urology, University Hospital of Tübingen, Tübingen, Germany.
  • John Kelly
    Department of Urology, University College London Hospital, London, UK.
  • Prokar Dasgupta
  • Carl Wijburg
    Department of Urology, Robotic Surgery, Rijnstate Hospital, Arnhem, The Netherlands.
  • Justin W Collins
  • Mihir Desai
    Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine/Norris Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Henk G Van Der Poel
    Department Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Peter Wiklund
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.